Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Updated April 13th, 2022

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
Finally Some Progress For Esophageal Cancer Patients - New Immunotherapy Drugs Are Boosting Survival
NOW
PLAYING
41-year-old Mom's Stomach Pain Turned Out To Be Stage 4 Cancer
NOW
PLAYING
Woman, 48, Feels 'Annoying Pain' In Her Leg While Walking Her Beloved Dog Elvis: It Turned Out To Be Cancer
NOW
PLAYING
Von Hippel-Lindau: Epididymal Cystadenomas
NOW
PLAYING
Lifestyle host, 31, Tries to Lessen Perceived Embarrassment of Bowel Cancer Symptoms After Her Own Rare Diagnosis
NOW
PLAYING
Colon Cancer Survivor Sharon Osbourne, 69, Stands By Ozzy's Side During His Own Medical Procedures

Treatment: Making Wise Surgery Decisions

SEE MORE   

Treatment: Making Wise Surgery Decisions

There is plenty of marketing information out there about the best surgery techniques, and the best places to have your operation done. Doing your own research is crucial before committing to any treatment.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.